- 1) Kato, T., Fukushima, M., Kurozumi, S., and Noyori, R., Antitumor activity of Δ 7-prostaglandin A1 and Δ 12-prostaglandin J2 in vitro and in vivo. Cancer Res, 46, 3538-3542 (1986).
- 2) Sasaki, H., Takada, K., Terashita, Y., Ekimoto, H., Takahashi, K., Tsuru, T., and Fukushima, M., Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to Δ 7-prostaglandin A1 and Δ 12-prostaglandin J2. Gynecologic Oncology, 41, 36-40 (1991).
- 3) Ohno, K., Fukushima, M., Fujiwara, M., and Narumiya, S., Induction of 68,000-dalton heat shock proteins by cyclopentenone prostaglandins: Its association with prostaglandin-induced G1 block in cell cycle progression. J. Biol. Chem., 263, 19764-19770 (1988).
- 4) Ohno, K., Sakai, T., Fukushima, M., Narumiya, S., and Fujiwara, M., Site and mechanism of growth inhibition by prostaglandins: IV: Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells. J. Pharmacol. Exp. Ther., 245, 294-298 (1988).
- 5) Forman, B. E., Tontonoz, P., Chen, J., Brun. R. P., Spiegelman, B. M. and Evans, R. M., 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell, 83, 803-812 (1995).
- 6) Hitomi, M., Shu, J., Strom, D., Hiebert, S. W., Harter, M. L., and Stacey, D. W., Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J. Biol. Chem., 271, 9376-9383 (1996).
- 7) Gorspe, M., Wang, X., Guyton, K. Z., and Holbrook, N. J., Protective role of p21 (Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol, 16, 6654-6650 (1996).
- 8) Higashiyama, K., Niiya, K., Ozawa, T., Hayakawa, Y., Fujimaki, M., and Sakuragawa, N., Induction of c-fos protooncogene transcription and apoptosis by delta 12-prostaglandin J2 in human P1-21 myeloid leukemia and RC-K8 pre-B lymphoma cells. Prostaglandins, 52, 143-156 (1996).
- 9) Rossi, A., Elia, G., and Santoro, M. G., Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. U.S.A., 94, 746-750 (1997).
- 10) Suzuki, M., Mori, M., Niwa. T., Hirata, R., Furuta, K., Ishikawa, T., and Noyori, R., Chemical implications for antitumor and antiviral prostaglandins: reaction of Δ 7-prostaglandin A1 and prostaglandin A1 methyl esters with thiols. J. Am. Chem. Soc., 119, 2376-2385 (1997).
- 11) Suzuki, K., Siddique, T., Nishimura, H., Sekimoto, J., and Uyeda, M., Inhibition of DNA topoisomerases by microbial inhibitors. J. Enz. Inhib., 13, 41-55 (1998).
- 12) Suzuki, K., Sekimoto, J., Siddique, T., Kamiya, A., and Uyeda, M., Macrostatin, a novel macromolecular inhibitor of topoisomerases produced by Streptomyces avermitilis No. C-127. J. Enz. Inhib.(1998) in press.
- 13) Wang, J. C., DNA topoisomerases. Annu. Rev. Biochem., 54, 665-697 (1985).
- 14) D’Arpa, P., and Liu, L.F., Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta, 989, 163-177 (1989).
- 15) Liu, L. F., DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-357 (1989).
- 16) Ferro, A. M., and Olivera, B. M., Poly (ADP-ribosylation) of DNA topoisomerase I from calf thymus. J. Biol. Chem., 259, 547-554 (1984).
- 17) Schomburg, U., and Grosse, F., Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. Eur. J. Biochem., 160, 451-457 (1986).
- . 1984. p. 275- 289.
- 19) Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., and Hayashi, O., 9-Deoxy-Δ 9,12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. Sci. U.S.A., 81, 1317-1321 (1984).
- 20) Ohno, K., Fujiwara, M., Fukushima, M., and Narumiya, S., Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: Correlation with prostaglandin E2-induced growth inhibition. Biochem. Biophys. Res. Commun., 139, 808-815 (1986).
- 21) Narumiya, S., and Fukushima, M., Delta 12-prostaglandin, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. Biochem. Biophys. Res. Commun., 127, 739-745 (1985).
- 22) Fukushima, M., Prostaglandin J2, antitumor and antiviral activities and the mechanisms involved. Eicosanoids, 3, 189-199 (1990).
Full access
Inhibition of Topoisomerases by Antitumor Prostaglandins.
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.